KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Goodwill: 2009-2025

Historic Goodwill for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Sep 2025 value amounting to $196.2 million.

  • Biomarin Pharmaceutical's Goodwill changed negligibly% to $196.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $196.2 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Biomarin Pharmaceutical's Goodwill stood at $196.2 million, which was down 0.00% from $196.2 million recorded in Q2 2025.
  • Biomarin Pharmaceutical's Goodwill's 5-year high stood at $196.2 million during Q1 2021, with a 5-year trough of $196.2 million in Q1 2021.
  • For the 3-year period, Biomarin Pharmaceutical's Goodwill averaged around $196.2 million, with its median value being $196.2 million (2025).